These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27747937)

  • 21. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral potassium citrate treatment for idiopathic hypocitruria in children with calcium urolithiasis.
    Tekin A; Tekgul S; Atsu N; Bakkaloglu M; Kendi S
    J Urol; 2002 Dec; 168(6):2572-4. PubMed ID: 12441986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers.
    Fuselier HA; Ward DM; Lindberg JS; Allen JM; Husserl FE; Marcucci PA; Cole FE; Turnipseed J; Alam J; Kok DJ
    Urology; 1995 Jun; 45(6):942-6. PubMed ID: 7771027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate.
    Brardi S; Imperiali P; Cevenini G; Verdacchi T; Ponchietti R
    Arch Ital Urol Androl; 2012 Jun; 84(2):61-7. PubMed ID: 22908773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary citrate excretion in patients with renal stone: roles of leucocyte ATP citrate lyase activity and potassium salts therapy.
    Tosukhowong P; Borvonpadungkitti S; Prasongwatana V; Tungsanga K; Jutuporn S; Dissayabutr T; Reungjui S; Sriboonlue P
    Clin Chim Acta; 2002 Nov; 325(1-2):71-8. PubMed ID: 12367768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate.
    Jendle-Bengten C; Tiselius HG
    Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium and sodium intake and excretion in calcium stone forming patients.
    Martini LA; Cuppari L; Cunha MA; Schor N; Heilberg IP
    J Ren Nutr; 1998 Jul; 8(3):127-31. PubMed ID: 9724501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and dietary factors in urinary citrate excretion.
    Shah O; Assimos DG; Holmes RP
    J Endourol; 2005 Mar; 19(2):177-82. PubMed ID: 15798414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones.
    Chow K; Dixon J; Gilpin S; Kavanagh JP; Rao PN
    Kidney Int; 2004 May; 65(5):1724-30. PubMed ID: 15086911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
    Parks JH; Coe FL; Evan AP; Worcester EM
    Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment with potassium citrate and renal stones in medullary sponge kidney.
    Fabris A; Lupo A; Bernich P; Abaterusso C; Marchionna N; Nouvenne A; Gambaro G
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1663-8. PubMed ID: 20576821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.